CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
53 hedge funds and large institutions have $9.28M invested in Carisma Therapeutics in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
52% less capital invested
Capital invested by funds: $19.3M → $9.28M (-$10M)
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
Holders
53
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$354K | |
| 2 | +$243K | |
| 3 | +$243K | |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$115K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$111K |
Top Sellers
| 1 | -$1.56M | |
| 2 | -$927K | |
| 3 | -$669K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$373K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$283K |